Cargando…

Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes

Hypoglycemia in type 1 diabetes associates with changes in the pancreatic islet α cells, where the receptor for advanced glycation end products (RAGE) is highly expressed. This study compared islet RAGE expression in donors without diabetes, those at risk of, and those with type 1 diabetes. Laser-di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Sherman S., Lenchik, Nataliya, Mathews, Clayton, Pugliese, Alberto, McCarthy, Domenica A., Le Bagge, Selena, Ewing, Adam, Harris, Mark, Radford, Kristen J., Borg, Danielle J., Gerling, Ivan, Forbes, Josephine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412557/ https://www.ncbi.nlm.nih.gov/pubmed/37558746 http://dx.doi.org/10.1038/s41598-023-39243-x

Ejemplares similares

Advanced glycation end products as predictors of renal function in youth with type 1 diabetes
por: Forbes, Josephine M., et al.
Publicado: (2021)

Approaches to reduce false positives and false negatives in the analysis of microarray data: applications in type 1 diabetes research
por: Wu, Jian, et al.
Publicado: (2008)

Differences in gene expression profiles between individual islets from case #6213
por: Lenchik, Nataliya I, et al.
Publicado: (2014)

Analysis of the transcriptome of CD4 T-Lymphocytes from young Non-Obese Diabetic (NOD) mice suggests a key role for cytokines and apoptosis
por: Kakoola, Dorothy N, et al.
Publicado: (2008)

Transcriptional profiling of CD4 T-lymphocytes reveals abnormal gene expression in young prediabetic NOD mice
por: Kakoola, Dorothy N, et al.
Publicado: (2009)

Molecular pathway alterations in CD4 T-cells of nonobese diabetic (NOD) mice in the preinsulitis phase of autoimmune diabetes
por: Kakoola, Dorothy N., et al.
Publicado: (2014)

Detection of Antiviral Tissue Responses and Increased Cell Stress in the Pancreatic Islets of Newly Diagnosed Type 1 Diabetes Patients: Results From the DiViD Study
por: Krogvold, Lars, et al.
Publicado: (2022)

The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)
por: Zhuang, Aowen, et al.
Publicado: (2021)

Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?
por: Fotheringham, Amelia K., et al.
Publicado: (2022)

Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells
por: Leung, Sherman S., et al.
Publicado: (2022)

Molecular Phenotyping of Immune Cells from Young NOD Mice Reveals Abnormal Metabolic Pathways in the Early Induction Phase of Autoimmune Diabetes
por: Wu, Jian, et al.
Publicado: (2012)

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes
por: Fotheringham, Amelia K., et al.
Publicado: (2020)

Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes
por: Apaolaza, Paola S., et al.
Publicado: (2021)

Glucagon-Like Peptide-1 Triggers Protective Pathways in Pancreatic Beta-Cells Exposed to Glycated Serum
por: Puddu, Alessandra, et al.
Publicado: (2013)

Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients
por: Lee, Minyoung, et al.
Publicado: (2019)

Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development
por: Du, Chenping, et al.
Publicado: (2022)

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
por: Leung, Christopher, et al.
Publicado: (2016)

Short Duration Alagebrium Chloride Therapy Prediabetes Does Not Inhibit Progression to Autoimmune Diabetes in an Experimental Model
por: Borg, Danielle J., et al.
Publicado: (2021)

Involvement of the Clock Gene Rev-erb alpha in the Regulation of Glucagon Secretion in Pancreatic Alpha-Cells
por: Vieira, Elaine, et al.
Publicado: (2013)

Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
por: Fernando, Dinali H., et al.
Publicado: (2019)

An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
por: Puddu, Alessandra, et al.
Publicado: (2013)

CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells
por: Edlund, Anna, et al.
Publicado: (2017)

Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion
por: Zhuang, Aowen, et al.
Publicado: (2019)

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
por: Chang, Jui-Ting, et al.
Publicado: (2017)

Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson’s Disease
por: König, Annekatrin, et al.
Publicado: (2018)

Glucose controls glucagon secretion by directly modulating cAMP in alpha cells
por: Yu, Qian, et al.
Publicado: (2019)

Glucokinase intrinsically regulates glucose sensing and glucagon secretion in pancreatic alpha cells
por: Moede, Tilo, et al.
Publicado: (2020)

Modeling the Amino Acid Effect on Glucagon Secretion from Pancreatic Alpha Cells
por: Zmazek, Jan, et al.
Publicado: (2022)

Correction: Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
por: Chang, Jui-Ting, et al.
Publicado: (2023)

Collagen Glycation Detected by Its Intrinsic Fluorescence
por: Muir, Rhona, et al.
Publicado: (2021)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction
por: Borg, Danielle J., et al.
Publicado: (2017)

Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
por: Kurz, Alexander, et al.
Publicado: (2010)

Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition
por: Farzadfard, Azad, et al.
Publicado: (2022)

Abnormal regulation of glucagon secretion by human islet alpha cells in the absence of beta cells
por: Liu, Wei, et al.
Publicado: (2019)

Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs) – induced apoptosis
por: Zhan, Yi, et al.
Publicado: (2012)

Direct Effects of D-Chiro-Inositol on Insulin Signaling and Glucagon Secretion of Pancreatic Alpha Cells
por: Filippello, Agnese, et al.
Publicado: (2020)

Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia
por: Asadi, Farzad, et al.
Publicado: (2021)

Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial
por: Baye, Estifanos, et al.
Publicado: (2017)

Silver nanoparticle interactions with glycated and non-glycated human serum albumin mediate toxicity
por: Park, Hee-Yon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_90ogaf5j13msgako5lv8099bpl